Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8263940 | 1.00 | HSD17B10 (0.42) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL9999939 | 1.00 | HSD17B10 (0.42) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL7901287 | 0.97 | HSD17B10 (0.44) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL27220429 | 0.95 | HSD17B10 (0.42) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL15965458 | 0.91 | HSD17B10 (0.41) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL18805113 | 0.88 | USP2 (0.53) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL12883079 | 0.88 | USP2 (0.53) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL11046670 | 0.88 | USP2 (0.53) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL31145340 | 0.88 | HSD17B10 (0.43) | HSD17B10LPAR5USP2ALDH1A1KDM4E | |
| SCHEMBL15965450 | 0.88 | MEN1 (0.43) | HSD17B10LPAR5USP2ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250243167-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-07-31 | — | — | US | disclosed |
| US-12275708-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-04-15 | — | — | US | disclosed |
| US-20240254088-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-08-01 | — | — | US | disclosed |
| US-11932603-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-03-19 | — | — | US | disclosed |
| US-20220227711-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-07-21 | — | — | US | disclosed |
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2022-05-17 | — | — | US | disclosed |
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-06-18 | — | — | US | disclosed |
| EP-3019575-B1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-12-19 | — | — | EP | disclosed |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2017-11-09 | — | — | US | disclosed |
| WO-2016193748-A1 | COMPOSITION | THE UNIVERSITY OF BIRMINGHAM (GB) | 2016-12-08 | — | — | WO | disclosed |
| EP-3019575-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | Siemens Healthcare Diagnostics Inc. (US) | 2016-05-18 | — | — | EP | disclosed |
| WO-2015006174-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2015-01-15 | — | — | WO | disclosed |
| US-6656252-B2 | Polymer separation membrane | DAISO CO., LTD. (JP) | 2003-12-02 | — | — | US | disclosed |
| US-20030110947-A1 | Polymer separation membrane | RENESAS TECHNOLOGY CORP. (JP) | 2003-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190037-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-20250243167-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-20170320830-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-20240254088-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-12275708-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-11332445-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-20220227711-A1 | HYDROPHILIC HIGH QUANTUM YIELD ACRIDINIUM ESTERS WITH IMPROVED STABILITY AND FAST LIGHT EMISSION | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
| US-11932603-B2 | Hydrophilic high quantum yield acridinium esters with improved stability and fast light emission | ACR, HACD3, FCGR3B | HSD17B10 1776/4885LPAR5 4354/4885USP2 2789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.